| 000 | 01471nam a2200349Ia 4500 | ||
|---|---|---|---|
| 001 | EBC3564092 | ||
| 003 | MiAaPQ | ||
| 005 | 20240121062954.0 | ||
| 006 | m o d | | ||
| 007 | cr cn||||||||| | ||
| 008 | 910307s2006 dcu sb 000 0 eng d | ||
| 020 | _z0309101611 | ||
| 035 | _a(MiAaPQ)EBC3564092 | ||
| 035 | _a(Au-PeEL)EBL3564092 | ||
| 035 | _a(CaPaEBR)ebr10126250 | ||
| 035 | _a(CaONFJC)MIL46558 | ||
| 035 | _a(OCoLC)70289130 | ||
| 040 |
_aMiAaPQ _cMiAaPQ _dMiAaPQ |
||
| 050 | 4 |
_aRM301 _b.E97 2006 |
|
| 245 | 0 | 0 |
_aExploring the role of antiviral drugs in the eradication of polio _h[electronic resource] : _bworkshop report / _cCommittee on Development of a Polio Antiviral and Its Potential Role in Global Poliomyelitis Eradication. |
| 250 | _a2nd ed. | ||
| 260 |
_aWashington, DC : _bThe National Academies Press, _cc2006. |
||
| 300 | _ax, 72 p. | ||
| 504 | _aIncludes bibliographical references. | ||
| 533 | _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
| 650 | 0 | _aPublic health. | |
| 650 | 0 | _aPharmacology. | |
| 655 | 4 | _aElectronic books. | |
| 710 | 2 |
_aNational Research Council (U.S.). _bCommittee on Development of a Polio Antiviral and Its Potential Role in Global Poliomyelitis Eradication. |
|
| 710 | 2 | _aProQuest (Firm) | |
| 856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=3564092 _zClick to View |
| 999 |
_c233552 _d233552 |
||